Matches in Wikidata for { <http://www.wikidata.org/entity/Q83912999> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q83912999 description "article scientifique publié en 2006" @default.
- Q83912999 description "artículu científicu espublizáu en xunu de 2006" @default.
- Q83912999 description "scientific article published on 01 June 2006" @default.
- Q83912999 description "wetenschappelijk artikel" @default.
- Q83912999 description "наукова стаття, опублікована в червні 2006" @default.
- Q83912999 name "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 name "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 type Item @default.
- Q83912999 label "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 label "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 prefLabel "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 prefLabel "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 P1433 Q83912999-60E0D9CA-EF0F-42AC-91C5-60A59D7E6D9E @default.
- Q83912999 P1476 Q83912999-2FCAFE24-9DB0-4030-88B4-AD156F2643C0 @default.
- Q83912999 P2093 Q83912999-008A2555-9041-4C96-8A8C-6B565256F494 @default.
- Q83912999 P2093 Q83912999-755AE8FB-9DC8-4482-9092-55FC38995A3F @default.
- Q83912999 P304 Q83912999-6625ADFC-5C4A-4934-BF9F-43E43652B4A6 @default.
- Q83912999 P31 Q83912999-261DEE40-D679-4CBB-8C7F-2FE7C95D62B9 @default.
- Q83912999 P356 Q83912999-0541EB43-AEFA-4C14-A6C6-AECC67AFEC6A @default.
- Q83912999 P433 Q83912999-648A95E0-1629-4031-B4F4-3CFC08BF92B2 @default.
- Q83912999 P478 Q83912999-96F9961D-8B4A-4AF3-81FC-06CBA0EC4C76 @default.
- Q83912999 P50 Q83912999-DD374274-78D1-477C-AC09-E84D4087BEC4 @default.
- Q83912999 P577 Q83912999-7399EEC6-B997-4B13-9D82-C4B2356C267D @default.
- Q83912999 P698 Q83912999-23612C45-2743-4B71-82BD-90DC10A4D057 @default.
- Q83912999 P921 Q83912999-B48B3C6C-2423-477A-ABF4-14000998D9E1 @default.
- Q83912999 P356 JO060588D @default.
- Q83912999 P698 16749814 @default.
- Q83912999 P1433 Q898967 @default.
- Q83912999 P1476 "Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide" @default.
- Q83912999 P2093 "Kiyoshi Tomioka" @default.
- Q83912999 P2093 "Yoshito Kawamoto" @default.
- Q83912999 P304 "4706-4709" @default.
- Q83912999 P31 Q13442814 @default.
- Q83912999 P356 "10.1021/JO060588D" @default.
- Q83912999 P433 "12" @default.
- Q83912999 P478 "71" @default.
- Q83912999 P50 Q61167940 @default.
- Q83912999 P577 "2006-06-01T00:00:00Z" @default.
- Q83912999 P698 "16749814" @default.
- Q83912999 P921 Q214514 @default.